Fundraising Fox
/Companies
Sign in

Synvect

San Diego, US · Founded 2022 · 6 employees on LinkedIn · 6 known investors

Find your way into Synvect

Each arrow is one introduction. Sign up to fill in the first one.

608 people can intro you to Pooja

Ask Craig Matturro to introduce you to Pooja Y. Patel

You →Craig · together at Bonafide Health →Pooja

399 people can intro you to Nikolay

Ask Jamie Chen to introduce you to Nikolay Kandul

You →Jamie · together at Synvect →Nikolay

Sign up to find every way you can get introduced to Synvect

  • Your email: who you already know at Synvect, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Synvect team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Synvect develops ngSIT (next-generation sterile insect technique) technology to control mosquito-borne disease vectors through genetic engineering. The company serves public health organizations and disease control programs targeting mosquito-borne diseases worldwide.

AgTechBiotechClimate TechDeep TechHealthtechImpact & Social Good

Founders & leadership

Synvect was founded in 2022 by Nikolay Kandul, Omar Akbari, Pooja Y. Patel, and Ravi Solanki.

NKNikolay Kandul
Nikolay KandulCo-founder & CEONikolay Kandul is co-founder and CEO of Synvect, a biotechnology company developing genetic engineering solutions for mosquito control. He has background and expertise in entomology, evolutionary biology, genetics, and molecular biology.
OAOmar Akbari
Omar AkbariCo-founder & CSO
PYPooja Y. Patel
Pooja Y. PatelCo-founder & CBOPooja Y. Patel is co-founder and chief business officer of Synvect, which develops genetic engineering technology to control disease-carrying mosquitoes. She has a background in epidemiology.
RSRavi Solanki
Ravi SolankiCo-founder

Investors · 6

NuFund Venture Grouplisted by NuFund Venture GroupSan Diego · $1M

How we know: NuFund Venture Group's portfolio page · funding news · Not right? Tell us

Service Provider Capitallisted by Service Provider CapitalVail
Bill & Melinda Gates FoundationreportedSeattle

How we know: funding news · Not right? Tell us

RedbudreportedAustin

How we know: funding news · Not right? Tell us

Redbud VCreportedColumbia · $50K – $150K

How we know: the VCSheet dataset · Not right? Tell us

Funding

SEC filings, press & company announcements

$3M disclosed across 1 of 2 rounds · 2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Synvect Secures $3M Seed Round to Combat Mosquito-Borne Diseases with CRISPR Technology - BioSpacebiospace.com · Mar 2025Synvect Raises $3M in Seed Fundingfinsmes.com · Mar 2025

Frequently asked questions

What does Synvect do?
Synvect develops ngSIT (next-generation sterile insect technique) technology to control mosquito-borne disease vectors through genetic engineering. The company serves public health organizations and disease control programs targeting mosquito-borne diseases worldwide.
Who founded Synvect?
Synvect was founded by Nikolay Kandul, Omar Akbari, Pooja Y. Patel, Ravi Solanki in 2022.
Who are Synvect's investors?
Synvect's investors include Antler, NuFund Venture Group, Service Provider Capital, Bill & Melinda Gates Foundation, Redbud, Redbud VC.
How much funding has Synvect raised?
Synvect has disclosed $3M raised across 1 of its 2 known rounds.
Where is Synvect headquartered?
Synvect is headquartered in San Diego, US.